European Medicines Agency Revises Nonclinical Safety Study Guidelines

The European Medicines Agency (EMA) has updated its ICH guideline M3(R2) for non-clinical safety studies. This revised guidance is crucial for the conduct of human clinical trials and the marketing authorization of pharmaceuticals. It provides scientific recommendations for assessing and overseeing risk management activities for human medicines, impacting drug development and regulatory processes.